Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Astra presents data on novel series of cPLA2 inhibitors

Sep. 9, 1998

Enbrel efficacy demonstrated in juvenile RA patients

Sep. 7, 1998

MDX-CD4 development progresses, triggering milestone payment from Eisai

Sep. 7, 1998

Substituted pyrimidines from Amgen inhibit cytokine production

Sep. 7, 1998

Antiadhesion agents prepared and evaluated at Hoechst

Sep. 7, 1998

MMP inhibitors in early development at British Biotech

Sep. 7, 1998

Dual 5-LO and COX-2 inhibitors for inflammatory disorders

Sep. 3, 1998

Zeneca patents new peptides for autoimmune/inflammatory disorders

Sep. 2, 1998

New treatment for osteoarthritis pain now available in the U.K.

Aug. 31, 1998

New agent for the prevention of osteoarthritis identified at Roche Bioscience

Aug. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...